All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
Interim results of the JULIET trial of CTL019 in R/R DLBCL
NICE grants approval to tisagenlecleucel (Kymriah®) for patients with previously treated DLBCL
The prognosis for patients with DLBCL is generally poor with limited treatment options. The NICE approval of tisagenlecleucel provides the opportunity to...
Implementation of CAR T-cell therapy in the real world - A round table discussion
The Lymphoma Hub is pleased to report a summary of real-world experiences of chimeric antigen receptor (CAR) T-cell implementation as discussed at the 2nd European CAR...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox